ICAM-1: Isoforms and phenotypes

Journal of Immunology

Volumn 192, Issue 10, 2014, Pages 4469-4474

  Ramos, Theresa N ^a,b   Bullard, Daniel C ^c   Barnum, Scott R ^a,b  

^a University of Alabama at Birmingham   (United States)

^b The University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; ISOPROTEIN;

ALTERNATIVE RNA SPLICING; ARTICLE; BRAIN MALARIA; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL DISEASE; EXTRACELLULAR MATRIX; GENE DELETION; GENE EXPRESSION REGULATION; HUMAN; ICAM 1 GENE; IMMUNOPATHOGENESIS; MULTIPLE SCLEROSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SEPTIC SHOCK;

ALTERNATIVE SPLICING; ANIMALS; HUMANS; IMMUNOLOGICAL SYNAPSES; INTERCELLULAR ADHESION MOLECULE-1; MICE; MICE, TRANSGENIC; PROTEIN ISOFORMS; PROTEOLYSIS;

EID: 84901256586     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400135     Document Type: Article

References (73)

1. Harlan, J. M., R. K. Winn, N. B. Vedder, C. M. Doerschuk, and C. L. Rice. 1992. Adhesion: Its Role in Inflammatory Disease. W. H. Freeman and Company, New York.
2. Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301-314.
3. Liu, L., and P. Kubes. 2003. Molecular mechanisms of leukocyte recruitment: organ-specific mechanisms of action. Thromb. Haemost. 89: 213-220.
4. Steeber, D. A., G. M. Venturi, and T. F. Tedder. 2005. A new twist to the leukocyte adhesion cascade: intimate cooperation is key. Trends Immunol. 26: 9-12.
5. Carman, C. V., P. T. Sage, T. E. Sciuto, M. A. de la Fuente, R. S. Geha, H. D. Ochs, H. F. Dvorak, A. M. Dvorak, and T. A. Springer. 2007. Transcellular diapedesis is initiated by invasive podosomes. Immunity 26: 784-797.
6. Staunton, D. E., S. D. Marlin, C. Stratowa, M. L. Dustin, and T. A. Springer. 1988. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 52: 925-933.
7. Lee, S. J., and E. N. Benveniste. 1999. Adhesion molecule expression and regulation on cells of the central nervous system. J. Neuroimmunol. 98: 77-88.
8. Roebuck, K. A., and A. Finnegan. 1999. Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J. Leukoc. Biol. 66: 876-888.
9. Limb, G. A., L. Webster, H. Soomro, S. Janikoun, and J. Shilling. 1999. Platelet expression of tumour necrosis factor-alpha (TNF-alpha), TNF receptors and intercellular adhesion molecule-1 (ICAM-1) in patients with proliferative diabetic retinopathy. Clin. Exp. Immunol. 118: 213-218.
10. Hubbard, A. K., and R. Rothlein. 2000. Intercellular adhesion molecule-1 (ICAM- 1) expression and cell signaling cascades. Free Radic. Biol. Med. 28: 1379-1386.
11. Koning, G. A., R. M. Schiffelers, and G. Storm. 2002. Endothelial cells at inflammatory sites as target for therapeutic intervention. Endothelium 9: 161-171.
12. Muro, S., and V. R. Muzykantov. 2005. Targeting of antioxidant and antithrombotic drugs to endothelial cell adhesion molecules. Curr. Pharm. Des. 11: 2383-2401.
13. Tailor, A., D. Cooper, and D. N. Granger. 2005. Platelet-vessel wall interactions in the microcirculation. Microcirculation 12: 275-285.
14. Almenar-Queralt, A., A. Duperray, L. A. Miles, J. Felez, and D. C. Altieri. 1995. Apical topography and modulation of ICAM-1 expression on activated endothelium. Am. J. Pathol. 147: 1278-1288.
15. Scholz, D., B. Devaux, A. Hirche, B. Pöltzsch, B. Kropp, W. Schaper, and J. Schaper. 1996. Expression of adhesion molecules is specific and time-dependent in cytokine-stimulated endothelial cells in culture. Cell Tissue Res. 284: 415-423.
16. Pober, J. S., M. A. Gimbrone, Jr., L. A. Lapierre, D. L. Mendrick, W. Fiers, R. Rothlein, and T. A. Springer. 1986. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J. Immunol. 137: 1893-1896.
17. Dustin, M. L., R. Rothlein, A. K. Bhan, C. A. Dinarello, and T. A. Springer. 1986. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 137: 245-254.
18. Hua, S. 2013. Targeting sites of inflammation: intercellular adhesion molecule-1 as a target for novel inflammatory therapies. Front. Pharmacol. 4: 127.
19. Lebedeva, T., M. L. Dustin, and Y. Sykulev. 2005. ICAM-1 co-stimulates target cells to facilitate antigen presentation. Curr. Opin. Immunol. 17: 251-258.
20. Scott, D. W., T. S. Dunn, M. E. Ballestas, S. H. Litovsky, and R. P. Patel. 2013. Identification of a high-mannose ICAM-1 glycoform: effects of ICAM-1 hypoglycosylation on monocyte adhesion and outside in signaling. Am. J. Physiol. Cell Physiol. 305: C228-C237.
21. Scott, D. W., and R. P. Patel. 2013. Endothelial heterogeneity and adhesion molecules N-glycosylation: implications in leukocyte trafficking in inflammation. Glycobiology 23: 622-633.
22. Kirchhausen, T., D. E. Staunton, and T. A. Springer. 1993. Location of the domains of ICAM-1 by immunolabeling and single-molecule electron microscopy. J. Leukoc. Biol. 53: 342-346.
23. Chen, X., T. D. Kim, C. V. Carman, L. Z. Mi, G. Song, and T. A. Springer. 2007. Structural plasticity in Ig superfamily domain 4 of ICAM-1 mediates cell surface dimerization. Proc. Natl. Acad. Sci. USA 104: 15358-15363.
24. Miller, J., R. Knorr, M. Ferrone, R. Houdei, C. P. Carron, and M. L. Dustin. 1995. Intercellular adhesion molecule-1 dimerization and its consequences for adhesion mediated by lymphocyte function associated-1. J. Exp. Med. 182: 1231-1241.
25. Diamond, M. S., D. E. Staunton, S. D. Marlin, and T. A. Springer. 1991. Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell 65: 961-971.
26. McCourt, P. A. G., B. Ek, N. Forsberg, and S. Gustafson. 1994. Intercellular adhesion molecule-1 is a cell surface receptor for hyaluronan. J. Biol. Chem. 269: 30081-30084.
27. Languino, L. R., A. Duperray, K. J. Joganic, M. Fornaro, G. B. Thornton, and D. C. Altieri. 1995. Regulation of leukocyte-endothelium interaction and leukocyte transendothelial migration by intercellular adhesion molecule 1-fibrinogen recognition. Proc. Natl. Acad. Sci. USA 92: 1505-1509.
28. Ockenhouse, C. F., R. Betageri, T. A. Springer, and D. E. Staunton. 1992. Plasmodium falciparum-infected erythrocytes bind ICAM-1 at a site distinct from LFA- 1, Mac-1, and human rhinovirus. Cell 68: 63-69.
29. Smith, J. D., A. G. Craig, N. Kriek, D. Hudson-Taylor, S. Kyes, T. Fagan, R. Pinches, D. I. Baruch, C. I. Newbold, and L. H. Miller. 2000. Identification of a Plasmodium falciparum intercellular adhesion molecule-1 binding domain: a parasite adhesion trait implicated in cerebral malaria Proc. Natl. Acad. Sci. USA 97: 1766-1771..
30. [Published erratum appears in 2006 Proc. Natl. Acad. Sci. USA 103: 12209]
31. Tse, M. T., K. Chakrabarti, C. Gray, C. E. Chitnis, and A. Craig. 2004. Divergent binding sites on intercellular adhesion molecule-1 (ICAM-1) for variant Plasmodium falciparum isolates. Mol. Microbiol. 51: 1039-1049.
32. Brown, A., L. Turner, S. Christoffersen, K. A. Andrews, T. Szestak, Y. Zhao, S. Larsen, A. G. Craig, and M. K. Higgins. 2013. Molecular architecture of a complex between an adhesion protein from the malaria parasite and intracellular adhesion molecule 1. J. Biol. Chem. 288: 5992-6003.
33. Frick, C., A. Odermatt, K. Zen, K. J. Mandell, H. Edens, R. Portmann, L. Mazzucchelli, D. L. Jaye, and C. A. Parkos. 2005. Interaction of ICAM-1 with beta 2-integrin CD11c/CD18: characterization of a peptide ligand that mimics a putative binding site on domain D4 of ICAM-1. Eur. J. Immunol. 35: 3610-3621.
34. Choi, J., J. Choi, and S. U. Nham. 2010. Characterization of the residues of aX Idomain and ICAM-1 mediating their interactions. Mol. Cells 30: 227-234.
35. Greenwood, J., S. J. Heasman, J. I. Alvarez, A. Prat, R. Lyck, and B. Engelhardt. 2011. Review: leucocyte-endothelial cell crosstalk at the blood-brain barrier: a prerequisite for successful immune cell entry to the brain. Neuropathol. Appl. Neurobiol. 37: 24-39.
36. Lynch, K. W. 2004. Consequences of regulated pre-mRNA splicing in the immune system. Nat. Rev. Immunol. 4: 931-940.
37. Heyd, F., and K. W. Lynch. 2011. Degrade, move, regroup: signaling control of splicing proteins. Trends Biochem. Sci. 36: 397-404.
38. Martinez, N. M., and K. W. Lynch. 2013. Control of alternative splicing in immune responses: many regulators, many predictions, much still to learn. Immunol. Rev. 253: 216-236.
39. Ergun, A., G. Doran, J. C. Costello, H. H. Paik, J. J. Collins, D. Mathis, and C. Benoist; ImmGen Consortium. 2013. Differential splicing across immune system lineages. Proc. Natl. Acad. Sci. USA 110: 14324-14329.
40. Giorelli, M., A. De Blasi, G. Defazio, C. Avolio, L. Iacovelli, P. Livrea, and M. Trojano. 2002. Differential regulation of membrane bound and soluble ICAM 1 in human endothelium and blood mononuclear cells: effects of interferon beta-1a. Cell Commun. Adhes. 9: 259-272.
41. King, P. D., E. T. Sandberg, A. Selvakumar, P. Fang, A. L. Beaudet, and B. Dupont. 1995. Novel isoforms of murine intercellular adhesion molecule-1 generated by alternative RNA splicing. J. Immunol. 154: 6080-6093.
42. Ochietti, B., P. Lemieux, A. V. Kabanov, S. Vinogradov, Y. St-Pierre, and V. Alakhov. 2002. Inducing neutrophil recruitment in the liver of ICAM-1- deficient mice using polyethyleneimine grafted with Pluronic P123 as an organspecific carrier for transgenic ICAM-1. Gene Ther. 9: 939-945.
43. Robledo, O., A. Papaioannou, B. Ochietti, C. Beauchemin, D. Legault, A. Cantin, P. D. King, C. Daniel, V. Y. Alakhov, E. F. Potworowski, and Y. St-Pierre. 2003. ICAM-1 isoforms: specific activity and sensitivity to cleavage by leukocyte elastase and cathepsin G. Eur. J. Immunol. 33: 1351-1360.
44. van Den Engel, N. K., E. Heidenthal, A. Vinke, H. Kolb, and S. Martin. 2000. Circulating forms of intercellular adhesion molecule (ICAM)-1 in mice lacking membranous ICAM-1. Blood 95: 1350-1355.
45. Wakatsuki, T., K. Kimura, F. Kimura, N. Shinomiya, M. Ohtsubo, M. Ishizawa, and M. Yamamoto. 1995. A distinct mRNA encoding a soluble form of ICAM-1 molecule expressed in human tissues. Cell Adhes. Commun. 3: 283-292.
46. Champagne, B., P. Tremblay, A. Cantin, and Y. St Pierre. 1998. Proteolytic cleavage of ICAM-1 by human neutrophil elastase. J. Immunol. 161: 6398-6405.
47. Grenier, D., and C. Bodet. 2008. Streptococcus suis stimulates ICAM-1 shedding from microvascular endothelial cells. FEMS Immunol. Med. Microbiol. 54: 271-276.
48. Mizgerd, J. P., M. R. Spieker, and M. M. Lupa. 2002. Exon truncation by alternative splicing of murine ICAM-1. Physiol. Genomics 12: 47-51.
49. Sligh, J. E., Jr., C. M. Ballantyne, S. S. Rich, H. K. Hawkins, C. W. Smith, A. Bradley, and A. L. Beaudet. 1993. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc. Natl. Acad. Sci. USA 90: 8529-8533.
50. Xu, H., J. A. Gonzalo, Y. St Pierre, I. R. Williams, T. S. Kupper, R. S. Cotran, T. A. Springer, and J. C. Gutierrez-Ramos. 1994. Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice. J. Exp. Med. 180: 95-109.
51. Dunne, J. L., R. G. Collins, A. L. Beaudet, C. M. Ballantyne, and K. Ley. 2003. Mac-1, but not LFA-1, uses intercellular adhesion molecule-1 to mediate slow leukocyte rolling in TNF-alpha-induced inflammation. J. Immunol. 171: 6105-6111.
52. Bullard, D. C., X. Hu, T. R. Schoeb, R. G. Collins, A. L. Beaudet, and S. R. Barnum. 2007. Intercellular adhesion molecule-1 expression is required on multiple cell types for the development of experimental autoimmune encephalomyelitis. J. Immunol. 178: 851-857.
53. Cox, M. A., S. R. Barnum, D. C. Bullard, and A. J. Zajac. 2013. ICAM-1- dependent tuning of memory CD8 T-cell responses following acute infection. Proc. Natl. Acad. Sci. USA 110: 1416-1421.
54. Ramos, T. N., D. C. Bullard, M. M. Darley, K. McDonald, D. F. Crawford, and S. R. Barnum. 2013. Experimental cerebral malaria develops independently of endothelial expression of intercellular adhesion molecule-1 (icam-1). J. Biol. Chem. 288: 10962-10966.
55. Bullard, D. C., X. Hu, D. Crawford, K. McDonald, T. N. Ramos, and S. R. Barnum. 2014. Expression of a single ICAM-1 isoform on T cells is sufficient for development of experimental autoimmune encephalomyelitis. Eur. J. Immunol. In press.
56. Baxter, A. G. 2007. The origin and application of experimental autoimmune encephalomyelitis. Nat. Rev. Immunol. 7: 904-912.
57. Constantinescu, C. S., N. Farooqi, K. O'Brien, and B. Gran. 2011. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br. J. Pharmacol. 164: 1079-1106.
58. Schulz, M., and B. Engelhardt. 2005. The circumventricular organs participate in the immunopathogenesis of experimental autoimmune encephalomyelitis. Cerebrospinal Fluid Res. 2:8.
59. Linker, R. A., M. Reinhardt, M. Bendszus, G. Ladewig, A. Briel, M. Schirner, M. Mäurer, and P. Hauff. 2005. In vivo molecular imaging of adhesion molecules in experimental autoimmune encephalomyelitis (EAE). J. Autoimmun. 25: 199-205.
60. Batoulis, H., M. S. Recks, K. Addicks, and S. Kuerten. 2011. Experimental autoimmune encephalomyelitis-achievements and prospective advances. APMIS 119: 819-830.
61. Jones, M. V., T. T. Nguyen, C. A. Deboy, J. W. Griffin, K. A. Whartenby, D. A. Kerr, and P. A. Calabresi. 2008. Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis. J. Neuroimmunol. 199: 83-93.
62. Samoilova, E. B., J. L. Horton, and Y. Chen. 1998. Experimental autoimmune encephalomyelitis in intercellular adhesion molecule-1-deficient mice. Cell. Immunol. 190: 83-89.
63. Hu, X., S. R. Barnum, J. E. Wohler, T. R. Schoeb, and D. C. Bullard. 2010. Differential ICAM-1 isoform expression regulates the development and progression of experimental autoimmune encephalomyelitis. Mol. Immunol. 47: 1692-1700.
64. van der Heyde, H. C., J. Nolan, V. Combes, I. Gramaglia, and G. E. Grau. 2006. A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol. 22: 503-508.
65. Haldar, K., S. C. Murphy, D. A. Milner, and T. E. Taylor. 2007. Malaria: mechanisms of erythrocytic infection and pathological correlates of severe disease. Annu. Rev. Pathol. 2: 217-249.
66. Berendt, A. R., D. L. Simmons, J. Tansey, C. I. Newbold, and K. Marsh. 1989. Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum. Nature 341: 57-59.
67. Willimann, K., H. Matile, N. A. Weiss, and B. A. Imhof. 1995. In vivo sequestration of Plasmodium falciparum-infected human erythrocytes: a severe combined immunodeficiency mouse model for cerebral malaria. J. Exp. Med. 182: 643-653.
68. Newbold, C., P. Warn, G. Black, A. Berendt, A. Craig, B. Snow, M. Msobo, N. Peshu, and K. Marsh. 1997. Receptor-specific adhesion and clinical disease in Plasmodium falciparum. Am. J. Trop. Med. Hyg. 57: 389-398.
69. Yipp, B. G., M. J. Hickey, G. Andonegui, A. G. Murray, S. Looareesuwan, P. Kubes, and M. Ho. 2007. Differential roles of CD36, ICAM-1, and P-selectin in Plasmodium falciparum cytoadherence in vivo. Microcirculation 14: 593-602.
70. Sinden, R. E., G. A. Butcher, and A. L. Beetsma. 2002. Maintenance of the Plasmodium berghei life cycle. Methods Mol. Med. 72: 25-40.
71. Engwerda, C., E. Belnoue, A. C. Gruner, and L. Rénia. 2005. Experimental models of cerebral malaria. Curr. Top. Microbiol. Immunol. 297: 103-143.
72. Lamb, T. J., D. E. Brown, A. J. Potocnik, and J. Langhorne. 2006. Insights into the immunopathogenesis of malaria using mouse models. Expert Rev. Mol. Med. 8: 1-22.
73. Ho, M., M. J. Hickey, A. G. Murray, G. Andonegui, and P. Kubes. 2000. Visualization of Plasmodium falciparum-endothelium interactions in human microvasculature: mimicry of leukocyte recruitment. J. Exp. Med. 192: 1205-1211.